The global Osteoarthritis Pain market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

It is also known as degenerative joint disease, hypertrophic arthritis, and degenerative arthritis, and is most commonly prevalent in older (above 60 years of age) and middle-aged people (between 40-59 years of age).

This report aims to provide a comprehensive presentation of the global market for Osteoarthritis Pain, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Osteoarthritis Pain.

Report Scope

The Osteoarthritis Pain market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Osteoarthritis Pain market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Osteoarthritis Pain manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Osteoarthritis Pain Market Report

Report Metric	Details
Report Name	Osteoarthritis Pain Market
Segment by Type	Oral Non-Oral
Segment by Application	Hospital Pharmacy Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Abbott Laboratories, Johnson & Johnson, Novartis International, Pfizer, AbbVie, Abiogen Pharma, Afferent Pharmaceuticals, Astellas Pharma, BioDelivery Sciences International, Crystal Genomics, Cytori Therapeutics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Osteoarthritis Pain manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Osteoarthritis Pain in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Osteoarthritis Pain Market report?

Ans: The main players in the Osteoarthritis Pain Market are Abbott Laboratories, Johnson & Johnson, Novartis International, Pfizer, AbbVie, Abiogen Pharma, Afferent Pharmaceuticals, Astellas Pharma, BioDelivery Sciences International, Crystal Genomics, Cytori Therapeutics

What are the Application segmentation covered in the Osteoarthritis Pain Market report?

Ans: The Applications covered in the Osteoarthritis Pain Market report are Hospital, Pharmacy, Other

What are the Type segmentation covered in the Osteoarthritis Pain Market report?

Ans: The Types covered in the Osteoarthritis Pain Market report are Oral, Non-Oral

1 Osteoarthritis Pain Market Overview

1.1 Product Overview and Scope of Osteoarthritis Pain

1.2 Osteoarthritis Pain Segment by Type

1.2.1 Global Osteoarthritis Pain Market Value Comparison by Type (2024-2030)

1.2.2 Oral

1.2.3 Non-Oral

1.3 Osteoarthritis Pain Segment by Application

1.3.1 Global Osteoarthritis Pain Market Value by Application: (2024-2030)

1.3.2 Hospital

1.3.3 Pharmacy

1.3.4 Other

1.4 Global Osteoarthritis Pain Market Size Estimates and Forecasts

1.4.1 Global Osteoarthritis Pain Revenue 2019-2030

1.4.2 Global Osteoarthritis Pain Sales 2019-2030

1.4.3 Global Osteoarthritis Pain Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Osteoarthritis Pain Market Competition by Manufacturers

2.1 Global Osteoarthritis Pain Sales Market Share by Manufacturers (2019-2024)

2.2 Global Osteoarthritis Pain Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Osteoarthritis Pain Average Price by Manufacturers (2019-2024)

2.4 Global Osteoarthritis Pain Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Osteoarthritis Pain, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Osteoarthritis Pain, Product Type & Application

2.7 Osteoarthritis Pain Market Competitive Situation and Trends

2.7.1 Osteoarthritis Pain Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Osteoarthritis Pain Players Market Share by Revenue

2.7.3 Global Osteoarthritis Pain Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Osteoarthritis Pain Retrospective Market Scenario by Region

3.1 Global Osteoarthritis Pain Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Osteoarthritis Pain Global Osteoarthritis Pain Sales by Region: 2019-2030

3.2.1 Global Osteoarthritis Pain Sales by Region: 2019-2024

3.2.2 Global Osteoarthritis Pain Sales by Region: 2025-2030

3.3 Global Osteoarthritis Pain Global Osteoarthritis Pain Revenue by Region: 2019-2030

3.3.1 Global Osteoarthritis Pain Revenue by Region: 2019-2024

3.3.2 Global Osteoarthritis Pain Revenue by Region: 2025-2030

3.4 North America Osteoarthritis Pain Market Facts & Figures by Country

3.4.1 North America Osteoarthritis Pain Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Osteoarthritis Pain Sales by Country (2019-2030)

3.4.3 North America Osteoarthritis Pain Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Osteoarthritis Pain Market Facts & Figures by Country

3.5.1 Europe Osteoarthritis Pain Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Osteoarthritis Pain Sales by Country (2019-2030)

3.5.3 Europe Osteoarthritis Pain Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Osteoarthritis Pain Market Facts & Figures by Country

3.6.1 Asia Pacific Osteoarthritis Pain Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Osteoarthritis Pain Sales by Country (2019-2030)

3.6.3 Asia Pacific Osteoarthritis Pain Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Osteoarthritis Pain Market Facts & Figures by Country

3.7.1 Latin America Osteoarthritis Pain Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Osteoarthritis Pain Sales by Country (2019-2030)

3.7.3 Latin America Osteoarthritis Pain Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Osteoarthritis Pain Market Facts & Figures by Country

3.8.1 Middle East and Africa Osteoarthritis Pain Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Osteoarthritis Pain Sales by Country (2019-2030)

3.8.3 Middle East and Africa Osteoarthritis Pain Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Osteoarthritis Pain Sales by Type (2019-2030)

4.1.1 Global Osteoarthritis Pain Sales by Type (2019-2024)

4.1.2 Global Osteoarthritis Pain Sales by Type (2025-2030)

4.1.3 Global Osteoarthritis Pain Sales Market Share by Type (2019-2030)

4.2 Global Osteoarthritis Pain Revenue by Type (2019-2030)

4.2.1 Global Osteoarthritis Pain Revenue by Type (2019-2024)

4.2.2 Global Osteoarthritis Pain Revenue by Type (2025-2030)

4.2.3 Global Osteoarthritis Pain Revenue Market Share by Type (2019-2030)

4.3 Global Osteoarthritis Pain Price by Type (2019-2030)

5 Segment by Application

5.1 Global Osteoarthritis Pain Sales by Application (2019-2030)

5.1.1 Global Osteoarthritis Pain Sales by Application (2019-2024)

5.1.2 Global Osteoarthritis Pain Sales by Application (2025-2030)

5.1.3 Global Osteoarthritis Pain Sales Market Share by Application (2019-2030)

5.2 Global Osteoarthritis Pain Revenue by Application (2019-2030)

5.2.1 Global Osteoarthritis Pain Revenue by Application (2019-2024)

5.2.2 Global Osteoarthritis Pain Revenue by Application (2025-2030)

5.2.3 Global Osteoarthritis Pain Revenue Market Share by Application (2019-2030)

5.3 Global Osteoarthritis Pain Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Abbott Laboratories

6.1.1 Abbott Laboratories Corporation Information

6.1.2 Abbott Laboratories Description and Business Overview

6.1.3 Abbott Laboratories Osteoarthritis Pain Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Abbott Laboratories Osteoarthritis Pain Product Portfolio

6.1.5 Abbott Laboratories Recent Developments/Updates

6.2 Johnson & Johnson

6.2.1 Johnson & Johnson Corporation Information

6.2.2 Johnson & Johnson Description and Business Overview

6.2.3 Johnson & Johnson Osteoarthritis Pain Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Johnson & Johnson Osteoarthritis Pain Product Portfolio

6.2.5 Johnson & Johnson Recent Developments/Updates

6.3 Novartis International

6.3.1 Novartis International Corporation Information

6.3.2 Novartis International Description and Business Overview

6.3.3 Novartis International Osteoarthritis Pain Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Novartis International Osteoarthritis Pain Product Portfolio

6.3.5 Novartis International Recent Developments/Updates

6.4 Pfizer

6.4.1 Pfizer Corporation Information

6.4.2 Pfizer Description and Business Overview

6.4.3 Pfizer Osteoarthritis Pain Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Pfizer Osteoarthritis Pain Product Portfolio

6.4.5 Pfizer Recent Developments/Updates

6.5 AbbVie

6.5.1 AbbVie Corporation Information

6.5.2 AbbVie Description and Business Overview

6.5.3 AbbVie Osteoarthritis Pain Sales, Revenue and Gross Margin (2019-2024)

6.5.4 AbbVie Osteoarthritis Pain Product Portfolio

6.5.5 AbbVie Recent Developments/Updates

6.6 Abiogen Pharma

6.6.1 Abiogen Pharma Corporation Information

6.6.2 Abiogen Pharma Description and Business Overview

6.6.3 Abiogen Pharma Osteoarthritis Pain Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Abiogen Pharma Osteoarthritis Pain Product Portfolio

6.6.5 Abiogen Pharma Recent Developments/Updates

6.7 Afferent Pharmaceuticals

6.6.1 Afferent Pharmaceuticals Corporation Information

6.6.2 Afferent Pharmaceuticals Description and Business Overview

6.6.3 Afferent Pharmaceuticals Osteoarthritis Pain Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Afferent Pharmaceuticals Osteoarthritis Pain Product Portfolio

6.7.5 Afferent Pharmaceuticals Recent Developments/Updates

6.8 Astellas Pharma

6.8.1 Astellas Pharma Corporation Information

6.8.2 Astellas Pharma Description and Business Overview

6.8.3 Astellas Pharma Osteoarthritis Pain Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Astellas Pharma Osteoarthritis Pain Product Portfolio

6.8.5 Astellas Pharma Recent Developments/Updates

6.9 BioDelivery Sciences International

6.9.1 BioDelivery Sciences International Corporation Information

6.9.2 BioDelivery Sciences International Description and Business Overview

6.9.3 BioDelivery Sciences International Osteoarthritis Pain Sales, Revenue and Gross Margin (2019-2024)

6.9.4 BioDelivery Sciences International Osteoarthritis Pain Product Portfolio

6.9.5 BioDelivery Sciences International Recent Developments/Updates

6.10 Crystal Genomics

6.10.1 Crystal Genomics Corporation Information

6.10.2 Crystal Genomics Description and Business Overview

6.10.3 Crystal Genomics Osteoarthritis Pain Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Crystal Genomics Osteoarthritis Pain Product Portfolio

6.10.5 Crystal Genomics Recent Developments/Updates

6.11 Cytori Therapeutics

6.11.1 Cytori Therapeutics Corporation Information

6.11.2 Cytori Therapeutics Osteoarthritis Pain Description and Business Overview

6.11.3 Cytori Therapeutics Osteoarthritis Pain Sales, Revenue and Gross Margin (2019-2024)

6.11.4 Cytori Therapeutics Osteoarthritis Pain Product Portfolio

6.11.5 Cytori Therapeutics Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Osteoarthritis Pain Industry Chain Analysis

7.2 Osteoarthritis Pain Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Osteoarthritis Pain Production Mode & Process

7.4 Osteoarthritis Pain Sales and Marketing

7.4.1 Osteoarthritis Pain Sales Channels

7.4.2 Osteoarthritis Pain Distributors

7.5 Osteoarthritis Pain Customers

8 Osteoarthritis Pain Market Dynamics

8.1 Osteoarthritis Pain Industry Trends

8.2 Osteoarthritis Pain Market Drivers

8.3 Osteoarthritis Pain Market Challenges

8.4 Osteoarthritis Pain Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Abbott Laboratories

Johnson & Johnson

Novartis International

Pfizer Inc

AbbVie

Abiogen Pharma

Afferent Pharmaceuticals

Astellas Pharma

BioDelivery Sciences International

Crystal Genomics

Cytori Therapeutics

List of Tables

Table 1. Global Osteoarthritis Pain Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Osteoarthritis Pain Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Osteoarthritis Pain Market Competitive Situation by Manufacturers in 2023

Table 4. Global Osteoarthritis Pain Sales (Units) of Key Manufacturers (2019-2024)

Table 5. Global Osteoarthritis Pain Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Osteoarthritis Pain Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Osteoarthritis Pain Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Osteoarthritis Pain Average Price (USD/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Osteoarthritis Pain, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Osteoarthritis Pain, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Osteoarthritis Pain, Product Type & Application

Table 12. Global Key Manufacturers of Osteoarthritis Pain, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Osteoarthritis Pain by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Osteoarthritis Pain as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Osteoarthritis Pain Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Osteoarthritis Pain Sales by Region (2019-2024) & (Units)

Table 18. Global Osteoarthritis Pain Sales Market Share by Region (2019-2024)

Table 19. Global Osteoarthritis Pain Sales by Region (2025-2030) & (Units)

Table 20. Global Osteoarthritis Pain Sales Market Share by Region (2025-2030)

Table 21. Global Osteoarthritis Pain Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Osteoarthritis Pain Revenue Market Share by Region (2019-2024)

Table 23. Global Osteoarthritis Pain Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Osteoarthritis Pain Revenue Market Share by Region (2025-2030)

Table 25. North America Osteoarthritis Pain Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Osteoarthritis Pain Sales by Country (2019-2024) & (Units)

Table 27. North America Osteoarthritis Pain Sales by Country (2025-2030) & (Units)

Table 28. North America Osteoarthritis Pain Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Osteoarthritis Pain Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Osteoarthritis Pain Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Osteoarthritis Pain Sales by Country (2019-2024) & (Units)

Table 32. Europe Osteoarthritis Pain Sales by Country (2025-2030) & (Units)

Table 33. Europe Osteoarthritis Pain Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Osteoarthritis Pain Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Osteoarthritis Pain Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Osteoarthritis Pain Sales by Region (2019-2024) & (Units)

Table 37. Asia Pacific Osteoarthritis Pain Sales by Region (2025-2030) & (Units)

Table 38. Asia Pacific Osteoarthritis Pain Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Osteoarthritis Pain Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Osteoarthritis Pain Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Osteoarthritis Pain Sales by Country (2019-2024) & (Units)

Table 42. Latin America Osteoarthritis Pain Sales by Country (2025-2030) & (Units)

Table 43. Latin America Osteoarthritis Pain Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Osteoarthritis Pain Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Osteoarthritis Pain Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Osteoarthritis Pain Sales by Country (2019-2024) & (Units)

Table 47. Middle East & Africa Osteoarthritis Pain Sales by Country (2025-2030) & (Units)

Table 48. Middle East & Africa Osteoarthritis Pain Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Osteoarthritis Pain Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Osteoarthritis Pain Sales (Units) by Type (2019-2024)

Table 51. Global Osteoarthritis Pain Sales (Units) by Type (2025-2030)

Table 52. Global Osteoarthritis Pain Sales Market Share by Type (2019-2024)

Table 53. Global Osteoarthritis Pain Sales Market Share by Type (2025-2030)

Table 54. Global Osteoarthritis Pain Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Osteoarthritis Pain Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Osteoarthritis Pain Revenue Market Share by Type (2019-2024)

Table 57. Global Osteoarthritis Pain Revenue Market Share by Type (2025-2030)

Table 58. Global Osteoarthritis Pain Price (USD/Unit) by Type (2019-2024)

Table 59. Global Osteoarthritis Pain Price (USD/Unit) by Type (2025-2030)

Table 60. Global Osteoarthritis Pain Sales (Units) by Application (2019-2024)

Table 61. Global Osteoarthritis Pain Sales (Units) by Application (2025-2030)

Table 62. Global Osteoarthritis Pain Sales Market Share by Application (2019-2024)

Table 63. Global Osteoarthritis Pain Sales Market Share by Application (2025-2030)

Table 64. Global Osteoarthritis Pain Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Osteoarthritis Pain Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Osteoarthritis Pain Revenue Market Share by Application (2019-2024)

Table 67. Global Osteoarthritis Pain Revenue Market Share by Application (2025-2030)

Table 68. Global Osteoarthritis Pain Price (USD/Unit) by Application (2019-2024)

Table 69. Global Osteoarthritis Pain Price (USD/Unit) by Application (2025-2030)

Table 70. Abbott Laboratories Corporation Information

Table 71. Abbott Laboratories Description and Business Overview

Table 72. Abbott Laboratories Osteoarthritis Pain Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 73. Abbott Laboratories Osteoarthritis Pain Product

Table 74. Abbott Laboratories Recent Developments/Updates

Table 75. Johnson & Johnson Corporation Information

Table 76. Johnson & Johnson Description and Business Overview

Table 77. Johnson & Johnson Osteoarthritis Pain Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 78. Johnson & Johnson Osteoarthritis Pain Product

Table 79. Johnson & Johnson Recent Developments/Updates

Table 80. Novartis International Corporation Information

Table 81. Novartis International Description and Business Overview

Table 82. Novartis International Osteoarthritis Pain Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 83. Novartis International Osteoarthritis Pain Product

Table 84. Novartis International Recent Developments/Updates

Table 85. Pfizer Corporation Information

Table 86. Pfizer Description and Business Overview

Table 87. Pfizer Osteoarthritis Pain Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 88. Pfizer Osteoarthritis Pain Product

Table 89. Pfizer Recent Developments/Updates

Table 90. AbbVie Corporation Information

Table 91. AbbVie Description and Business Overview

Table 92. AbbVie Osteoarthritis Pain Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 93. AbbVie Osteoarthritis Pain Product

Table 94. AbbVie Recent Developments/Updates

Table 95. Abiogen Pharma Corporation Information

Table 96. Abiogen Pharma Description and Business Overview

Table 97. Abiogen Pharma Osteoarthritis Pain Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 98. Abiogen Pharma Osteoarthritis Pain Product

Table 99. Abiogen Pharma Recent Developments/Updates

Table 100. Afferent Pharmaceuticals Corporation Information

Table 101. Afferent Pharmaceuticals Description and Business Overview

Table 102. Afferent Pharmaceuticals Osteoarthritis Pain Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 103. Afferent Pharmaceuticals Osteoarthritis Pain Product

Table 104. Afferent Pharmaceuticals Recent Developments/Updates

Table 105. Astellas Pharma Corporation Information

Table 106. Astellas Pharma Description and Business Overview

Table 107. Astellas Pharma Osteoarthritis Pain Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 108. Astellas Pharma Osteoarthritis Pain Product

Table 109. Astellas Pharma Recent Developments/Updates

Table 110. BioDelivery Sciences International Corporation Information

Table 111. BioDelivery Sciences International Description and Business Overview

Table 112. BioDelivery Sciences International Osteoarthritis Pain Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 113. BioDelivery Sciences International Osteoarthritis Pain Product

Table 114. BioDelivery Sciences International Recent Developments/Updates

Table 115. Crystal Genomics Corporation Information

Table 116. Crystal Genomics Description and Business Overview

Table 117. Crystal Genomics Osteoarthritis Pain Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 118. Crystal Genomics Osteoarthritis Pain Product

Table 119. Crystal Genomics Recent Developments/Updates

Table 120. Cytori Therapeutics Corporation Information

Table 121. Cytori Therapeutics Description and Business Overview

Table 122. Cytori Therapeutics Osteoarthritis Pain Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 123. Cytori Therapeutics Osteoarthritis Pain Product

Table 124. Cytori Therapeutics Recent Developments/Updates

Table 125. Key Raw Materials Lists

Table 126. Raw Materials Key Suppliers Lists

Table 127. Osteoarthritis Pain Distributors List

Table 128. Osteoarthritis Pain Customers List

Table 129. Osteoarthritis Pain Market Trends

Table 130. Osteoarthritis Pain Market Drivers

Table 131. Osteoarthritis Pain Market Challenges

Table 132. Osteoarthritis Pain Market Restraints

Table 133. Research Programs/Design for This Report

Table 134. Key Data Information from Secondary Sources

Table 135. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Osteoarthritis Pain

Figure 2. Global Osteoarthritis Pain Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Osteoarthritis Pain Market Share by Type in 2023 & 2030

Figure 4. Oral Product Picture

Figure 5. Non-Oral Product Picture

Figure 6. Global Osteoarthritis Pain Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Osteoarthritis Pain Market Share by Application in 2023 & 2030

Figure 8. Hospital

Figure 9. Pharmacy

Figure 10. Other

Figure 11. Global Osteoarthritis Pain Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 12. Global Osteoarthritis Pain Market Size (2019-2030) & (US$ Million)

Figure 13. Global Osteoarthritis Pain Sales (2019-2030) & (Units)

Figure 14. Global Osteoarthritis Pain Average Price (USD/Unit) & (2019-2030)

Figure 15. Osteoarthritis Pain Report Years Considered

Figure 16. Osteoarthritis Pain Sales Share by Manufacturers in 2023

Figure 17. Global Osteoarthritis Pain Revenue Share by Manufacturers in 2023

Figure 18. The Global 5 and 10 Largest Osteoarthritis Pain Players: Market Share by Revenue in 2023

Figure 19. Osteoarthritis Pain Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 20. Global Osteoarthritis Pain Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 21. North America Osteoarthritis Pain Sales Market Share by Country (2019-2030)

Figure 22. North America Osteoarthritis Pain Revenue Market Share by Country (2019-2030)

Figure 23. U.S. Osteoarthritis Pain Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 24. Canada Osteoarthritis Pain Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 25. Europe Osteoarthritis Pain Sales Market Share by Country (2019-2030)

Figure 26. Europe Osteoarthritis Pain Revenue Market Share by Country (2019-2030)

Figure 27. Germany Osteoarthritis Pain Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. France Osteoarthritis Pain Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. U.K. Osteoarthritis Pain Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. Italy Osteoarthritis Pain Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Russia Osteoarthritis Pain Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Asia Pacific Osteoarthritis Pain Sales Market Share by Region (2019-2030)

Figure 33. Asia Pacific Osteoarthritis Pain Revenue Market Share by Region (2019-2030)

Figure 34. China Osteoarthritis Pain Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. Japan Osteoarthritis Pain Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. South Korea Osteoarthritis Pain Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. India Osteoarthritis Pain Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. Australia Osteoarthritis Pain Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Taiwan Osteoarthritis Pain Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Indonesia Osteoarthritis Pain Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Thailand Osteoarthritis Pain Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Malaysia Osteoarthritis Pain Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Philippines Osteoarthritis Pain Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Latin America Osteoarthritis Pain Sales Market Share by Country (2019-2030)

Figure 45. Latin America Osteoarthritis Pain Revenue Market Share by Country (2019-2030)

Figure 46. Mexico Osteoarthritis Pain Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Brazil Osteoarthritis Pain Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Argentina Osteoarthritis Pain Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Middle East & Africa Osteoarthritis Pain Sales Market Share by Country (2019-2030)

Figure 50. Middle East & Africa Osteoarthritis Pain Revenue Market Share by Country (2019-2030)

Figure 51. Turkey Osteoarthritis Pain Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. Saudi Arabia Osteoarthritis Pain Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. UAE Osteoarthritis Pain Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 54. Global Sales Market Share of Osteoarthritis Pain by Type (2019-2030)

Figure 55. Global Revenue Market Share of Osteoarthritis Pain by Type (2019-2030)

Figure 56. Global Osteoarthritis Pain Price (USD/Unit) by Type (2019-2030)

Figure 57. Global Sales Market Share of Osteoarthritis Pain by Application (2019-2030)

Figure 58. Global Revenue Market Share of Osteoarthritis Pain by Application (2019-2030)

Figure 59. Global Osteoarthritis Pain Price (USD/Unit) by Application (2019-2030)

Figure 60. Osteoarthritis Pain Value Chain

Figure 61. Osteoarthritis Pain Production Process

Figure 62. Channels of Distribution (Direct Vs Distribution)

Figure 63. Distributors Profiles

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Viscosupplementation for Knee Osteoarthritis Market

Knee Osteoarthritis Treatment Market

Osteoarthritis Pain Market

Osteoarthritis Drugs Market

Osteoarthritis Medications Market

Hip Replacement Market

Rheumatology Therapeutics Market

Total Hip Replacement Market

Psoriatic Arthritis Therapeutics Market

Digital Therapeutics Market

RELATED REPORTS

Global Rheumatoid Arthritis Testing Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-33E11182

Thu Oct 17 00:00:00 UTC 2024

Add to Cart

Rheumatic Disorders Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-15X13281

Mon Oct 14 00:00:00 UTC 2024

Add to Cart

Rheumatology Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-29B5986

Sat Oct 12 00:00:00 UTC 2024

Add to Cart

Rheumatology Arthritis Therapeutics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-1J13864

Sat Oct 05 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions